• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰结直肠癌人群筛查的结肠镜检查要求

Colonoscopy requirements of population screening for colorectal cancer in New Zealand.

作者信息

Green Terri, Richardson Ann, Parry Susan

机构信息

Department of Management, University of Canterbury, Christchurch, New Zealand.

出版信息

N Z Med J. 2012 Jun 8;125(1356):85-95.

PMID:22729063
Abstract

AIM

To estimate the colonoscopy burden of introducing population screening for colorectal cancer in New Zealand.

METHODS

Screening for colorectal cancer using biennial immunochemical faecal occult blood tests offered to people aged 50-74 years of age was modelled using population estimates from Statistics New Zealand for 2011-2031. Modelling to determine colonoscopy requirements was based on participation and test positivity rates from published results of screening programmes. Estimates of the number of procedures required for ongoing adenoma surveillance were calculated using screening literature results of adenoma yield, and New Zealand Guidelines for Adenoma Surveillance. Sensitivity analysis was undertaken on key parameters.

RESULTS

For a test positivity of 6.4%, biennial screening using immunochemical faecal occult blood testing with a 60% participation rate, would require 18,000 colonoscopies nationally, increasing to 28,000 by 2031. The majority of procedures are direct referrals from a positive FOBT, with surveillance colonoscopy numbers building over time.

CONCLUSION

Colonoscopy requirements for immunochemical faecal occult blood based population screening for colorectal cancer are high. Significant expansion of services is required and careful management of surveillance procedures to ensure timely delivery of initial colonoscopies whilst maintaining symptomatic services. A model re-run informed by data from the screening pilot will allow improved estimates for the New Zealand setting.

摘要

目的

评估在新西兰引入结直肠癌人群筛查的结肠镜检查负担。

方法

利用新西兰统计局2011 - 2031年的人口估计数据,对向50 - 74岁人群每两年提供一次免疫化学粪便潜血检测进行结直肠癌筛查进行建模。基于已发表的筛查项目结果中的参与率和检测阳性率,对确定结肠镜检查需求进行建模。根据腺瘤检出率的筛查文献结果和新西兰腺瘤监测指南,计算持续腺瘤监测所需的检查数量。对关键参数进行敏感性分析。

结果

对于6.4%的检测阳性率,参与率为60%的每两年一次免疫化学粪便潜血检测筛查,全国将需要18,000例结肠镜检查,到2031年将增至28,000例。大多数检查是由粪便潜血检测阳性直接转诊而来,随着时间推移,监测结肠镜检查数量会增加。

结论

基于免疫化学粪便潜血检测的结直肠癌人群筛查对结肠镜检查的需求很高。需要大幅扩大服务,并对监测程序进行仔细管理,以确保及时进行初次结肠镜检查,同时维持针对有症状患者的服务。根据筛查试点数据重新运行模型将有助于更准确地估计新西兰的情况。

相似文献

1
Colonoscopy requirements of population screening for colorectal cancer in New Zealand.新西兰结直肠癌人群筛查的结肠镜检查要求
N Z Med J. 2012 Jun 8;125(1356):85-95.
2
Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?对非综合征性家族性结直肠癌风险患者进行粪便潜血定量检测能否预先确定其是否需要进行结肠镜检查?
Aliment Pharmacol Ther. 2006 Nov 15;24(10):1475-81. doi: 10.1111/j.1365-2036.2006.03152.x. Epub 2006 Oct 10.
3
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.在筛查人群中对粪便潜血愈创木脂法检测和免疫化学法检测用于结直肠癌筛查的随机对照比较。
Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.
4
From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?从筛查标准到结直肠癌筛查:新西兰能从其他国家学到什么?
N Z Med J. 2008 Aug 8;121(1279):84-95.
5
Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.基于粪便潜血试验且结肠镜检查依从性高的筛查计划对结直肠癌具有重大临床影响。
Br J Surg. 2009 May;96(5):533-40. doi: 10.1002/bjs.6568.
6
Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.对英国肠癌筛查计划中结肠镜检查的未来容量需求和支出进行建模。
Gut. 2008 Sep;57(9):1238-45. doi: 10.1136/gut.2007.146050. Epub 2008 Apr 25.
7
Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?高危结直肠肿瘤且粪便定量免疫化学检测阴性的患者能否推迟择期结肠镜检查?
Aliment Pharmacol Ther. 2010 Feb 15;31(4):523-33. doi: 10.1111/j.1365-2036.2009.04202.x. Epub 2009 Nov 19.
8
Colonoscopy: a review of its yield for cancers and adenomas by indication.结肠镜检查:按适应证对其癌症和腺瘤检出率的综述。
Am J Gastroenterol. 1995 Mar;90(3):353-65.
9
Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.新西兰结直肠癌人群筛查建议。国家卫生委员会结直肠癌人群筛查工作组成员。
N Z Med J. 1999 Jan 22;112(1080):4-6.
10
Prospects for population colorectal cancer screening in New Zealand.
N Z Med J. 2007 Jul 20;120(1258):U2633.

引用本文的文献

1
From small steps to big impact: what we learnt from the National Bowel Screening Programme.从小处着手,产生重大影响:我们从国家肠道筛查计划中学到了什么。
J R Soc N Z. 2025 Jul 16;55(5):1304-1321. doi: 10.1080/03036758.2025.2529350. eCollection 2025.